Beyond Air Posts Wider-Than-Expected $3.49 Loss as Revenue Edges Past Estimates
XAIR is trading near its 52-week low of $2.05 (6.3% above the low) on elevated volume (2.8× avg).
Summary
Beyond Air reported a Q2 FY2027 adjusted loss of $3.49 per share, wider than the $3.31 consensus, on revenue of $2.32 million that narrowly beat the $2.30 million estimate. The GAAP loss was $3.76 per share, a $7.82 million net loss for the quarter. This follows the October 8 preannouncement of roughly $2.3 million in preliminary revenue, which had already flagged the top line; the miss on the bottom line is the new information. The company is burning cash against a going-concern warning and only $9.8 million in cash at the last 10-Q, so the size of the quarterly loss matters more than the revenue beat. Shares are down 82.6% year to date and fell 8.7% during the quarter.
At the time of this announcement, XAIR was trading at $2.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.4M. The 52-week trading range was $2.05 to $53.20. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.